Abstract

Combined modality adjuvant therapy for high-risk endometrial cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
V Makker ... J.A Ledermann
Annals of Oncology | VOL. 33
V Makker, et. al.V Makker ... J.A Ledermann
08 Jun 2022
What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control
D Scott Mcmeekin
American Journal of Obstetrics and Gynecology | VOL. 205
D Scott McmeekinD Scott Mcmeekin
16 Sep 2011
Lymphadenectomy in endometrial cancer – Authors' reply
Wendi Qian ... Henry Kitchener
The Lancet | VOL. 373
Wendi Qian, et. al.Wendi Qian ... Henry Kitchener
01 Apr 2009
Reply
Charu Sharma
American Journal of Obstetrics and Gynecology | VOL. 206
Charu SharmaCharu Sharma
01 Feb 2012
View more papers

More From: The Lancet Oncology

Paper Title
Journal
Date
Author
Correction to Lancet Oncol 2024; 25: e126–35
-
The Lancet Oncology | VOL. 25
--
01 Jun 2024
Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics
Andrew M Scott ... Jason S Lewis
The Lancet Oncology | VOL. 25
Andrew M Scott, et. al.Andrew M Scott ... Jason S Lewis
01 Jun 2024
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities
May Abdel-Wahab ... Benjamin W Corn
The Lancet Oncology | VOL. 25
May Abdel-Wahab, et. al.May Abdel-Wahab ... Benjamin W Corn
01 Jun 2024
Cryptic metastatic calcification after radical nephrectomy in a patient with renal cell carcinoma
Shan Huang
The Lancet Oncology | VOL. 25
Shan HuangShan Huang
01 Jun 2024
View more papers